CRYSTALLINE SOLVATES AND COMPLEXES OF (1S) -1, 5-ANHYDRO-1-C- (3- ( (PHENYL) METHYL) PHENYL) -D-GLUCITOL DERIVATIVES WITH AMINO ACIDS AS SGLT2 INHIBITORS FOR THE TREATMENT OF DIABETES

The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a crystalline (2S,3R,4S,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl] -6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3,4,5-triol (S)-propylene glycol solvate (compound Ia) as SGLT2 inhibitor...

Full description

Saved in:
Bibliographic Details
Main Authors RAMAKRISHNAN, SRIVIDYA, DIMARCO, JOHN, D, DESHPANDE, PRASHANT, P, LAI, CHIAJEN, WANG, CHENCHI, SINGH, JANAK, NIRSCHL, ALEXANDRA, A, LOBINGER, HILDEGARD, BIEN, JEFFREY, T, GROSSO, JOHN, ANTHONY, RIEBEL, PETER, GOUGOUTAS, JACK, Z
Format Patent
LanguageEnglish
Published 30.07.2014
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a pharmaceutical composition comprising a therapeutically effective amount of a crystalline (2S,3R,4S,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl] -6-hydroxymethyl-2-methoxy-tetrahydro-pyran-3,4,5-triol (S)-propylene glycol solvate (compound Ia) as SGLT2 inhibitor for treating diabetes.
Bibliography:Application Number: SG20141002181S